Transamerica Financial Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $143 | Hold |
3
| – | – | ﹤0.01% | 513 |
|
2025
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 494 |
|
2024
Q4 | $1K | Sell |
3
-3
| -50% | -$1K | ﹤0.01% | 488 |
|
2024
Q3 | $1K | Sell |
6
-372
| -98% | -$62K | ﹤0.01% | 495 |
|
2024
Q2 | $22K | Hold |
378
| – | – | ﹤0.01% | 294 |
|
2024
Q1 | $23K | Hold |
378
| – | – | ﹤0.01% | 320 |
|
2023
Q4 | $21K | Sell |
378
-2
| -0.5% | -$111 | ﹤0.01% | 309 |
|
2023
Q3 | $19K | Sell |
380
-2
| -0.5% | -$100 | ﹤0.01% | 304 |
|
2023
Q2 | $22K | Hold |
382
| – | – | ﹤0.01% | 281 |
|
2023
Q1 | $21K | Sell |
382
-5
| -1% | -$275 | ﹤0.01% | 297 |
|
2022
Q4 | $21K | Buy |
387
+374
| +2,877% | +$20.3K | ﹤0.01% | 302 |
|
2022
Q3 | $1K | Sell |
13
-1
| -7% | -$77 | ﹤0.01% | 503 |
|
2022
Q2 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 515 |
|
2020
Q3 | – | Sell |
-6
| Closed | -$1K | – | 330 |
|
2020
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 413 |
|
2019
Q3 | – | Sell |
-6
| Closed | -$1K | – | 300 |
|
2019
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 466 |
|
2019
Q1 | – | Sell |
-6
| Closed | -$1K | – | 267 |
|
2018
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 434 |
|
2018
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 437 |
|
2018
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 404 |
|
2018
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 384 |
|
2017
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 367 |
|
2017
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 363 |
|
2017
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 337 |
|
2017
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 334 |
|
2016
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 370 |
|
2016
Q3 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 374 |
|
2015
Q1 | – | Sell |
-60
| Closed | -$2K | – | 914 |
|
2014
Q4 | $2K | Sell |
60
-27,030
| -100% | -$901K | ﹤0.01% | 609 |
|
2014
Q3 | $449K | Buy |
27,090
+1,950
| +8% | +$32.3K | 0.04% | 174 |
|
2014
Q2 | $428K | Buy |
+25,140
| New | +$428K | 0.04% | 190 |
|